Abstract
Background: A midtrimester cervical length (CL) <25 mm is associated with spontaneous preterm birth (sPTB). However, as CL ≥25 mm is not enough to exclude recurrence in high-risk patients, follow-up CL measurement later in pregnancy has been proposed. Objectives: To evaluate whether CL measurement at 26±1 weeks in asymptomatic high-risk patients improves the prediction of sPTB recurrence. Methods: A retrospective cohort of high-risk women because of previous sPTB was analyzed. Patients with a CL ≥25 mm at 20±1 weeks and subsequent CL measurement at 26±1 weeks were included. The exclusion criteria were incomplete follow-up, any treatment before CL assessments, and medically indicated preterm birth. The association and predictive performance of CL at 26±1 weeks for sPTB was studied. Results: Of 131 patients with a CL measurement at 26±1 weeks, 19 and 4.6% presented sPTB before 37 and 34 weeks, respectively. The rate of sPTB before 37 weeks was higher in women with a CL <25 mm (37.5 vs. 16.5%, RR 2.3 [1.07–4.8], p = 0.045), although the detection rate of CL at 26±1 weeks to predict sPTB before 37 weeks was 24% (95% CI 10–46%). The performance did not improve regardless of the selected cutoff. Conclusions: In asymptomatic high-risk patients, CL <25 mm at 26±1 weeks is associated with higher risk of sPTB. However, the prediction of recurrence by CL was low and did not improve, regardless of the selected cutoff.
References
1.
Beck S, Wojdyla D, Say L, Betran AP, Me rialdi M, Requejo JH, Rubens C, Menon R, van Look PFA: The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ 2010; 88: 31–38.
2.
Vintzileos AM, Visser GHA: Interventions for women with mid-trimester short cervix: are they effective? Which ones work? Ultrasound Obstet Gynecol 2016, Epub ahead of print.
3.
Conde-Agudelo A, Romero R: Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications. Am J Obstet Gynecol 2016; 214: 235–242.
4.
National Institute for Health and Care Excellence: Preterm labour and birth. 2015. https://www.nice.org.uk/guidance/ng25.
5.
Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006; 3:CD004454.
6.
Costantine MM, Weiner SJ: Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants: a meta-analysis. Obstet Gynecol 2009; 114: 354–364.
7.
Conde-Agudelo A, Romero R: Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol 2009; 200: 595–609.
8.
Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D: Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009; 1:CD004661.
9.
Hughes K, Kane SC, Araujo Júnior E, Da Sil va Costa F, Sheehan PM: Cervical length as a predictor for spontaneous preterm birth in high-risk singleton pregnancy: current knowledge. Ultrasound Obstet Gynecol 2016; 48: 7–15.
10.
Iams JD: Clinical practice. Prevention of preterm parturition. N Engl J Med 2014; 370: 254–261.
11.
Simham HN, Berguella V, Iams JD: Chapter 40 – Preterm labor and birth; in: Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice, ed 7. Elsevier, 2014, pp 624–653.e9.
12.
Kazemier BM, Buijs PE, Mignini L, Limpens J, de Groot CJ, Mol BW; EBM CONNECT: Impact of obstetric history on the risk of spontaneous preterm birth in singleton and multiple pregnancies: a systematic review. BJOG 2014; 121: 1197–1208; discussion 1209.
13.
Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, Thom E, McNellis D, Copper RL, Johnson F, Roberts JM: The length of the cervix and the risk of spontaneous premature delivery. N Engl J Med 1996; 334: 567–573.
14.
Society for Maternal-Fetal Medicine (SMFM); electronic address: [email protected]; McIntosh J, Feltovich H, Berghella V, Manuck T: The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention. Am J Obstet Gynecol 2016; 215:B2–B7.
15.
Owen J, Szychowski JM, Hankins G, Iams JD, Sheffield JS, Perez-Delboy A, Berghella V, Wing DA, Guzman ER; Vaginal Ultrasound Trial Consortium: Does midtrimester cervical length ≥25 mm predict preterm birth in high-risk women? Am J Obstet Gynecol 2010; 203: 393.e1–e5.
16.
Care AG, Sharp AN, Lane S, Roberts D, Watkins L, Alfirevic Z: Predicting preterm birth in women with previous preterm birth and cervical length ≥25 mm. Ultrasound Obstet Gynecol 2014; 43: 681–686.
17.
Melamed N, Hiersch L, Domniz N, Maresky A, Bardin R, Yogev Y: Predictive value of cervical length in women with threatened preterm labor. Obstet Gynecol 2013; 122: 1279–1287.
18.
Hiersch L, Yogev Y, Domniz N, Meizner I, Bardin R, Melamed N: The role of cervical length in women with threatened preterm labor: is it a valid predictor at any gestational age? Am J Obstet Gynecol 2014; 211: 532.e1–e9.
19.
Pagani G, Stagnati V, Fichera A, Prefumo F: Cervical length at mid-gestation in screening for preterm birth in twin pregnancy. Ultrasound Obstet Gynecol 2016; 48: 56–60.
20.
Gordon MC, McKenna DS, Stewart TL, Howard BC, Foster KF, Higby K, Cypher RL, Barth WH: Transvaginal cervical length scans to prevent prematurity in twins: a randomized controlled trial. Am J Obstet Gynecol 2016; 214: 277.e1–e7.
21.
Owen J, Yost N, Berghella V, Thom E, Swain M, Dildy GA 3rd, Miodovnik M, Langer O, Sibai B, McNellis D; National Institute of Child Health and Human Development, Maternal-Fetal Medicine Units Network: Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 2001; 286: 1340–1348.
22.
Melamed N, Pittini A, Hiersch L, Yogev Y, Korzeniewski SJ, Romero R, Barrett J: Do serial measurements of cervical length improve the prediction of preterm birth in asymptomatic women with twin gestations? Am J Obstet Gynecol 2016; 215: 616.e1–e14.
23.
Fox NS, Jean-Pierre C, Predanic M, Chasen ST: Short cervix: Is a follow-up measurement useful? Ultrasound Obstet Gynecol 2007; 29: 44–46.
24.
Crane JMG, Hutchens D: Follow-up cervical length in asymptomatic high-risk women and the risk of spontaneous preterm birth. J Perinatol 2011; 31: 318–323.
25.
Conde-Agudelo A, Romero R: Predictive accuracy of changes in transvaginal sonographic cervical length over time for preterm birth: a systematic review and metaanalysis. Am J Obstet Gynecol 2015; 213: 789–801.
26.
Iams JD: Cervical length – time to report the rate of change? Am J Obstet Gynecol 2014; 211: 443.
27.
Robinson HP, Fleming JE: A critical evaluation of sonar “crown-rump length” measurements. Br J Obstet Gynaecol 1975; 82: 702–710.
28.
To MS, Skentou C, Chan C, Zagaliki A, Nicolaides KH: Cervical assessment at the routine 23-week scan: standardizing techniques. Ultrasound Obstet Gynecol 2001; 17: 217–219.
29.
Dilek TUK, Yazici G, Gurbuz A, Tasdelen B, Gulhan S, Dilek B, Dilek S: Progressive cervical length changes versus single cervical length measurement by transvaginal ultrasound for prediction of preterm delivery. Gynecol Obstet Invest 2007; 64: 175–179.
30.
Moroz LA, Brock CO, Govindappagari S, Johnson DL, Leopold BH, Gyamfi-Bannerman C: Association between change in cervical length and spontaneous preterm birth in twin pregnancies. Am J Obstet Gynecol 2017; 216: 159.e1–e7.
31.
Sotiriadis A, Kavvadias A, Papatheodorou S, Paraskevaidis E, Makrydimas G: The value of serial cervical length measurements for the prediction of threatened preterm labour. Eur J Obstet Gynecol Reprod Biol 2010; 148: 17–20.
32.
Moroz LA, Simhan HN: Rate of sonographic cervical shortening and the risk of spontaneous preterm birth. Am J Obstet Gynecol 2012; 206: 234.e1–e5.
33.
Society for Maternal-Fetal Medicine (SMFM) Publications Committee: The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth. Am J Obstet Gynecol 2017; 216:B11–B13.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
